Correlation and integration of circulating miRNA and peripheral whole blood gene expression profiles in patients with venous thromboembolism

References

• Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden[J]. Arterioscler Thromb Vasc Biol. 2014;34(11):2363–2371.
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects[J]. Circ Res. 2016;118(9):1340–1347.
   PubMed Web of Science ®Google Scholar
• Keller K, Hobohm L, Ebner M, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J. 2020;41(4):522–529.
   PubMed Web of Science ®Google Scholar
• Fesmire FM, Brown MD, Espinosa JA, et al. Critical issues in the evaluation and management of adult patients presenting to the emergency department with suspected pulmonary embolism. Ann Emerg Med. 2011;57(6):628–652.
   PubMed Web of Science ®Google Scholar
• Xu XF, Yang YH, Zhai ZG, et al. Prevalence and incidence of deep venous thrombosis among patients in medical intensive care unit. Zhonghua Liu Xing Bing Xue Za Zhi. 2008;29(10):1034–1037.
   PubMedGoogle Scholar
• Zampetaki A, Willeit P, Drozdov I, et al. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res. 2012;93(4):555–562.
   PubMed Web of Science ®Google Scholar
• Kumar S, Williams D, Sur S, et al. Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis. Vasc Pharmacol. 2019;114:76–92.
   PubMed Web of Science ®Google Scholar
• Ultimo S, Zauli G, Martelli AM, et al. Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise. Oncotarget. 2018;9(24):17238–17254.
   PubMedGoogle Scholar
• Barutta F, Bellini S, Mastrocola R, et al. MicroRNA and microvascular complications of diabetes. Int J Endocrinol. 2018;2018:6890501.
   PubMed Web of Science ®Google Scholar
• Dewdney B, Trollope A, Moxon J, et al. Circulating MicroRNAs as biomarkers for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis. 2018;27(3):522–530.
   PubMed Web of Science ®Google Scholar
• Michota FA. Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process. J Gen Intern Med. 2007;22(12):1762–1770.
   PubMed Web of Science ®Google Scholar
• Xu H, Du X, Xu J, et al. Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function. PLoS Biol. 2020;18(2):e3000603.
   PubMed Web of Science ®Google Scholar
• Wang S, Min J, Yu Y, et al. Differentially expressed miRNAs in circulating exosomes between atrial fibrillation and sinus rhythm. J Thorac Dis. 2019;11(10):4337–4348.
   PubMed Web of Science ®Google Scholar
• Patil M, Henderson J, Luong H, et al. The art of intercellular wireless communications: exosomes in heart disease and therapy. Front Cell Dev Biol. 2019;7:315.
   PubMed Web of Science ®Google Scholar
• Sundar IK, Li D, Small RI. RNA-sequence analysis of plasma-derived extracellular vesicle miRNAs in smokers and patients with chronic obstructive pulmonary disease as circulating biomarkers. J Extracell Vesicles. 2019;8(1):1684816.
   PubMed Web of Science ®Google Scholar
• Chen J, Tian J, Tang X, et al. MiR-346 regulates CD4⁺CXCR5⁺ T cells in the pathogenesis of Graves’ disease. Endocrine. 2015;49(3):752–760.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Muñoz A, Martínez-Hernández R, Ramos-Leví AM, et al. Circulating microvesicles regulate Treg and Th17 differentiation in human autoimmune thyroid disorders. J Clin Endocrinol Metab. 2015;100(12):E1531–E1539.
   PubMed Web of Science ®Google Scholar
• Jerjes-Sánchez C, Villarreal-Umaña S, Ramírez-Rivera A, et al. Improving adjunctive treatment in pulmonary embolism and fibrinolytic therapy. The role of enoxaparin and weight-adjusted unfractionated heparin. J Thromb Thrombolysis. 2009;27(2):154–162.
   PubMed Web of Science ®Google Scholar
• Ali HO, Arroyo AB, González-Conejero R, et al. The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α. J Thromb Haemost. 2016;14(6):1226–1237.
   PubMed Web of Science ®Google Scholar
• Mills EW, Wangen J, Green R, et al. Dynamic regulation of a ribosome rescue pathway in erythroid cells and platelets. Cell Rep. 2016;17(1):1–10.
   PubMed Web of Science ®Google Scholar
• Fletcher SJ, Pisareva VP, Khan AO, et al. Role of the novel endoribonuclease SLFN14 and its disease-causing mutations in ribosomal degradation. RNA. 2018;24(7):939–949.
   PubMed Web of Science ®Google Scholar
• Gao W, Wang K, Zhang L, et al. Pharmacological inhibition of S6K1 facilitates platelet activation by enhancing Akt phosphorylation. Platelets. 2019;30(2):241–250.
   PubMed Web of Science ®Google Scholar
• Sundquist K, Ahmad A, Svensson PJ, et al. Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner. J Thromb Thrombolysis. 2018;46(2):154–165.
   PubMed Web of Science ®Google Scholar
• Deng HT, Liu HL, Zhai BB, et al. Vascular endothelial growth factor suppresses TNFSF15 production in endothelial cells by stimulating miR-31 and miR-20a expression via activation of Akt and Erk signals. FEBS Open Bio. 2016;7(1):108–117.
   PubMed Web of Science ®Google Scholar
• Zhang K, Cai HX, Gao S, et al. TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals. Oncotarget. 2016;7(43):69436–69449.
   PubMedGoogle Scholar
• Ergun S, Oztuzcu S. Sequence-based analysis of 5ʹUTR and coding regions of CASP3 in terms of miRSNPs and SNPs in targeting miRNAs. Comput Biol Chem. 2016;62:70–74.
   PubMed Web of Science ®Google Scholar
• Della Bella S, Calcaterra F, Bacci M, et al. Pathologic up-regulation of TNFSF15-TNFRSF25 axis sustains endothelial dysfunction in unprovoked venous thromboembolism. Cardiovasc Res. 2020;116(3):698–707.
   PubMed Web of Science ®Google Scholar
• Wang HW, Su SH, Wang YL, et al. MicroRNA-134 contributes to glucose-induced endothelial cell dysfunction and this effect can be reversed by far-infrared irradiation. PLoS One. 2016;11(1):e0147067.
   PubMed Web of Science ®Google Scholar
• Lo WY, Peng CT, Wang HJ. MicroRNA-146a-5p mediates high glucose-induced endothelial inflammation via targeting interleukin-1 receptor-associated Kinase 1 expression. Front Physiol. 2017;8:551.
   PubMed Web of Science ®Google Scholar
• Villasante A, Marturano-Kruik A, Ambati SR, et al. Recapitulating the size and cargo of tumor exosomes in a tissue-engineered model. Theranostics. 2016;6(8):1119–1130.
   PubMed Web of Science ®Google Scholar
• Dieudé M, Bell C, Turgeon J, et al. The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection. Sci Transl Med. 2015;7(318):318ra200.
   PubMed Web of Science ®Google Scholar
• Chyrchel B, Totoń-Żurańska J, Kruszelnicka O, et al. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: a preliminary report. Platelets. 2015;26(6):593–597.
   PubMed Web of Science ®Google Scholar
• Tan M, Yan HB, Li JN, et al. Thrombin stimulated platelet-derived exosomes inhibit platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells. Cell Physiol Biochem. 2016;38(6):2348–2365.
   PubMedGoogle Scholar